Last month, I received an email from Clinical Trials.gov alerting me to a new Phase II clinical trial for Etanercept.
Safety and Tolerability of Etanercept in Alzheimer's Disease
So far, this study is not yet open for participant recruitment. It appears the drug trial will be limited to one location, the Memory Assessment and Research Centre, Moorgreen Hospital Southampton, Hampshire, United Kingdom. The fact that Wyeth is one of the collaborators did get my attention.
Original content Bob DeMarco, the Alzheimer's Reading Room